Optics of spectacle lenses intended to treat myopia progression
- PMID: 38857035
- DOI: 10.1097/OPX.0000000000002140
Optics of spectacle lenses intended to treat myopia progression
Abstract
This is a review of the optics of various spectacle lenses that have been used in myopia control over the last 60 years, with emphasis on approximately the last 15 years.Myopia has become an increasing health problem worldwide, particularly in some East Asian countries. This has led to many attempts to slow its progression in children and reduce its endpoint value. This review is concerned with the optics of spectacle lenses for use in myopia control, from bifocal lenses to multisegment and diffusion optics lenses. Treatments are based on theories of the onset or progression of myopia. These include the hypotheses that eye growth and myopia in susceptible children may be stimulated by (1) poor accommodation response and the consequent hyperopic defocus with near vision tasks, (2) relative hyperopic peripheral refraction, and (3) high retinal image contrast as occurs in urban environments. Using spectacle lenses to slow myopia progression has a history of about 60 years. The review is laid out in approximately the order in which different types of lenses have been introduced: bifocals, conventional progressive addition lenses, undercorrection with single-vision lenses, specialized progressive addition lenses, defocus-incorporated multiple segments, diffusion optics, and concentric bifocals. In the review, some of the lenses are combined with an eye model to determine refractive errors for peripheral vision for the stationary eye and for foveal vision for the rotating eye. Numbers are provided for the reported success of particular designs in retarding myopia progression, but this is not an epidemiological paper, and there is no critical review of the findings. Some of the recent treatments, such as multiple segments, appear to reduce the eye growth and myopia progression by better than 50% over periods of up to 2 years.
Copyright © 2024 American Academy of Optometry.
Conflict of interest statement
Conflict of Interest Disclosure: None of the authors have reported a financial conflict of interest.
Similar articles
-
Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial.Trials. 2020 Mar 19;21(1):279. doi: 10.1186/s13063-020-4095-8. Trials. 2020. PMID: 32188478 Free PMC article.
-
Myopia control with positively aspherized progressive addition lenses: a 2-year, multicenter, randomized, controlled trial.Invest Ophthalmol Vis Sci. 2014 Sep 30;55(11):7177-88. doi: 10.1167/iovs.12-11462. Invest Ophthalmol Vis Sci. 2014. PMID: 25270192 Clinical Trial.
-
Real-world outcomes on myopia management efficacy of diverse segmented defocus optics (DSDO) and defocus incorporated multiple segments (DIMS) spectacle lenses in Chinese children: An initial 12-month prospective clinical study.J Optom. 2025 Jan-Mar;18(1):100533. doi: 10.1016/j.optom.2024.100533. Epub 2025 Jan 11. J Optom. 2025. PMID: 39799796 Free PMC article.
-
Advances in myopia control strategies for children.Br J Ophthalmol. 2025 Jan 28;109(2):165-176. doi: 10.1136/bjo-2023-323887. Br J Ophthalmol. 2025. PMID: 38777389 Review.
-
[The role of peripheral retinal defocus in myopia progression].Zhonghua Yan Ke Za Zhi. 2024 Jun 11;60(6):541-546. doi: 10.3760/cma.j.cn112142-20231024-00173. Zhonghua Yan Ke Za Zhi. 2024. PMID: 38825954 Review. Chinese.
Cited by
-
Is central vision (and a fovea) needed for emmetropisation?Ophthalmic Physiol Opt. 2025 Jun;45(4):941-946. doi: 10.1111/opo.13494. Epub 2025 Mar 20. Ophthalmic Physiol Opt. 2025. PMID: 40110950 Free PMC article. No abstract available.
-
Retinal "sweet spot" for myopia treatment.Sci Rep. 2024 Nov 5;14(1):26773. doi: 10.1038/s41598-024-78300-x. Sci Rep. 2024. PMID: 39501066 Free PMC article.
-
Retinal shadows of multisegment lenses in fundus imaging.Ophthalmic Physiol Opt. 2025 Jul;45(5):1098-1103. doi: 10.1111/opo.13524. Epub 2025 May 14. Ophthalmic Physiol Opt. 2025. PMID: 40366318 Free PMC article.
-
Oblique effects with multisegment spectacle lenses: 2. Ray tracing to determine power corrections.Ophthalmic Physiol Opt. 2025 May;45(3):790-798. doi: 10.1111/opo.13477. Epub 2025 Mar 10. Ophthalmic Physiol Opt. 2025. PMID: 40062513 Free PMC article.
-
Off-axis imagery through two multi-segment lenses for myopia treatment.Biomed Opt Express. 2025 Jul 16;16(8):3206-3221. doi: 10.1364/BOE.558990. eCollection 2025 Aug 1. Biomed Opt Express. 2025. PMID: 40809983 Free PMC article.
References
-
- Gwiazda J, Thorn F, Bauer J, Held R. Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci 1993;34:690–4.
-
- Charman WN. Near vision, lags of accommodation and myopia. Ophthalmic Physiol Opt 1999;19:126–33.
-
- Smith EL 3rd. Prentice Award Lecture 2010: A case for peripheral optical treatment strategies for myopia. Optom Vis Sci 2011;88:1029–44.
-
- Atchison DA, Rozema JJ. Technical notes on peripheral refraction, peripheral eye length and retinal shape determination. Ophthalmic Physiol Opt 2023;43:584–94.
-
- Rosén R, Lundström L, Unsbo P, Koh P. Have we misinterpreted the study of Hoogerheide et al. (1971)? Optom Vis Sci 2012;89:1235–7.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical